Rezolute, Inc.
RZLT · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Evans Daron: Form 4
Insider disclosure · Filed · Report period 21 Oct 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-K
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- RZLT · 76200L309 - Common Stock
Company details and SEC sources
CIK 0001509261 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- RZLT on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 275 Shoreline Drive, Suite 500, Redwood City, CA, 94065
- Incorporated in
- NV
- Fiscal year end
- 30 June
- Former names on EDGAR
- AntriaBio, Inc. (to 07 Dec 2017), FITS MY STYLE INC (to 11 Jan 2013)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields